Recognition and binding of mismatch repair proteins at an oncogenic hot spot

被引:9
|
作者
Edelbrock, M
He, HL
Schroering, A
Fernstrom, M
Bathala, S
Williams, KJ [1 ]
机构
[1] Med Coll Ohio, Dept Biochem & Canc Biol, Toledo, OH 43699 USA
[2] Ohio State Univ, Div Human Canc Genet, Columbus, OH 43210 USA
[3] Univ S Alabama, Dept Cell Biol & Neurosci, Mobile, AL 36688 USA
来源
BMC MOLECULAR BIOLOGY | 2005年 / 6卷
关键词
D O I
10.1186/1471-2199-6-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: The current investigation was undertaken to determine key steps differentiating G: T and G: A repair at the H-ras oncogenic hot spot within the nuclear environment because of the large difference in repair efficiency of these two mismatches. Results: Electrophoretic mobility shift ( gel shift) experiments demonstrate that DNA containing mismatched bases are recognized and bound equally efficiently by hMutS alpha in both MMR proficient and MMR deficient ( hMLHI-/-) nuclear extracts. Competition experiments demonstrate that while hMutSa predictably binds the G: T mismatch to a much greater extent than G: A, hMutSa demonstrates a surprisingly equal ratio of competitive inhibition for both G: T and G: A mismatch binding reactions at the H-ras hot spot of mutation. Further, mismatch repair assays reveal almost 2-fold higher efficiency of overall G: A repair (5'-nick directed correct MMR to G: C and incorrect repair to T: A), as compared to G: T overall repair. Conversely, correct MMR of G: T. G: C is significantly higher (96%) than that of G: A -> G: C (60%). Conclusion: Combined, these results suggest that initiation of correct MMR requires the contribution of two separate steps; initial recognition by hMutSa followed by subsequent binding. The 'avidity' of the binding step determines the extent of MMR pathway activation, or the activation of a different cellular pathway. Thus, initial recognition by hMutSa in combination with subsequent decreased binding to the G: A mismatch ( as compared to G: T) may contribute to the observed increased frequency of incorrect repair of G: A, resulting in the predominant GGC -> GTC (Gly -> Val) ras-activating mutation found in a high percentage of human tumors.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Sporadic colorectal polyps and mismatch repair proteins
    Molaei, Mahsa
    Yadollahzadeh, Mahdi
    Almasi, Shohreh
    Shivarani, Sepideh
    Fatemi, Seyed Reza
    Zali, Mohammad Reza
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2011, 54 (04) : 725 - 729
  • [22] Mismatch repair proteins in sporadic colorectal polyps
    Molaei, M.
    Yadollahzadeh, M.
    Almasi, S.
    Shivarani, S.
    Mashayekhi, R.
    Fatemi, S. R.
    Zali, M.
    HISTOPATHOLOGY, 2010, 57 : 84 - 85
  • [23] Mismatch repair proteins in pancreatic endocrine neoplasms
    Hsu, M.
    Srivastava, A.
    Mino-Kenudson, M.
    Deshpande, V.
    Lauwers, G. Y.
    MODERN PATHOLOGY, 2008, 21 : 305A - 306A
  • [24] Meiotic recombination intermediates and mismatch repair proteins
    Hoffmann, ER
    Borts, RH
    CYTOGENETIC AND GENOME RESEARCH, 2004, 107 (3-4) : 232 - 248
  • [25] Phosphorylation of mismatch repair proteins MSH2 and MSH6 affecting MutSα mismatch-binding activity
    Christmann, M
    Tomicic, MT
    Kaina, B
    NUCLEIC ACIDS RESEARCH, 2002, 30 (09) : 1959 - 1966
  • [26] In vitro studies of DNA mismatch repair proteins
    Geng, Hui
    Du, Chunwei
    Chen, Siying
    Salerno, Vincenzo
    Manfredi, Candela
    Hsieh, Peggy
    ANALYTICAL BIOCHEMISTRY, 2011, 413 (02) : 179 - 184
  • [27] Mismatch repair proteins and clinicopathologic factors in colorectal
    Molaei, M.
    Noorinayer, B.
    Ghanbarimothlagh, A.
    Mashayekhi, R.
    Ghiasi, S.
    Ahmadizadeh, Z.
    Zali, M.
    ANNALS OF ONCOLOGY, 2007, 18 : VII43 - VII43
  • [28] Mismatch Repair Proteins in Recurrent Prostate Cancer
    Jarzen, John
    Diamanduros, Andrew
    Scarpinato, Karin D.
    ADVANCES IN CLINICAL CHEMISTRY, VOL 60, 2013, 60 : 65 - 84
  • [29] Constitutional mismatch repair deficiency in a healthy child: On the spot diagnosis?
    Suerink, M.
    Potjer, T. P.
    Versluijs, A. B.
    ten Broeke, S. W.
    Tops, C. M.
    Wimmer, K.
    Nielsen, M.
    CLINICAL GENETICS, 2018, 93 (01) : 134 - 137
  • [30] Biophysical characterization of Gβγ "hot spot" binding small molecules: explaining Gβγ "hot spot" binding effector selectivity
    Seneviratne, Pramodh
    Wedekind, Joseph
    Burroughs, Michael
    Smrcka, Alan
    FASEB JOURNAL, 2009, 23